A Case Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic and Tractable Biomarkers in Male Breast Cancer

Humphries, MP orcid.org/0000-0003-1306-7012, Rajan, SS, Droop, A orcid.org/0000-0001-7695-7480 et al. (29 more authors) (2017) A Case Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic and Tractable Biomarkers in Male Breast Cancer. Clinical Cancer Research, 23 (10). pp. 2575-2583. ISSN 1078-0432

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016, American Association for Cancer Research. This is an author produced version of a paper published in Clinical Cancer Research. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: breast cancer; genomics; eIF; survival; mTOR inhibitor
Dates:
  • Published: May 2017
  • Accepted: 12 December 2016
  • Published (online): 16 December 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Pathology & Tumour Biology (Leeds)
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchL378
Expired: Use BreastCancerNow 605321NOT GIVEN
Yorkshire Cancer ResearchLPP030
Breast Cancer Cure NZNONE GIVEN
Depositing User: Symplectic Publications
Date Deposited: 16 Dec 2016 12:55
Last Modified: 16 Dec 2017 01:38
Published Version: https://doi.org/10.1158/1078-0432.CCR-16-1952
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/1078-0432.CCR-16-1952

Share / Export

Statistics